Drug
Vk2735 Drug
Vk2735 Drug: highest development phase Phase 1, developed by Viking Therapeutics. 1 trial record tracked on RxWires.
- Highest phase
- Phase 1
- Developer
- Viking Therapeutics
Trials
| Drug | Phase | Indication |
|---|---|---|
| VK2735 Drug NCT07838740 | Phase 1 | Obese Adults |
Latest
No recent events.
Follow Vk2735 Drug on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.